GEMC Stock Overview
United Medical Group Cy PLC offers healthcare services under the European Medical Center (EMC) brand name in Russia.
United Medical Group Cy Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₽403.90|
|52 Week High||₽1,325.60|
|52 Week Low||₽278.00|
|1 Month Change||0%|
|3 Month Change||-19.96%|
|1 Year Change||-53.59%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-56.36%|
Recent News & Updates
|GEMC||RU Healthcare||RU Market|
Return vs Industry: GEMC underperformed the Russian Healthcare industry which returned -32.7% over the past year.
Return vs Market: GEMC underperformed the Russian Market which returned -32.9% over the past year.
|GEMC Average Weekly Movement||16.4%|
|Healthcare Industry Average Movement||4.7%|
|Market Average Movement||4.9%|
|10% most volatile stocks in RU Market||8.5%|
|10% least volatile stocks in RU Market||2.9%|
Stable Share Price: GEMC is more volatile than 90% of Russian stocks over the past 3 months, typically moving +/- 16% a week.
Volatility Over Time: GEMC's weekly volatility has increased from 11% to 16% over the past year.
About the Company
United Medical Group Cy PLC offers healthcare services under the European Medical Center (EMC) brand name in Russia. It operates clinics in areas, such as children's, sports traumatology and orthopedics, oncology, gynecology and oncogynecology, dermatovenereology and allergology-immunology, weight correction, pain management, mammology, neurology and neurosurgery, otorhinolaryngology, head and neck surgery, ophthalmology, plastic surgery, psychiatry and psychotherapy, reproductive and prenatal medicine, heart and vascular, tropical medicine, ambulance and emergency department, maternity hospital, dental, therapeutic, urology, surgical, and aesthetic clinics, as well as diagnostic and rehabilitation centers, and center for robotic surgery. The company also offers COVID-19 diagnosis, treatment, rehabilitation, and vaccination services.
United Medical Group Cy Fundamentals Summary
|GEMC fundamental statistics|
Is GEMC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GEMC income statement (TTM)|
|Cost of Revenue||€160.04m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||1.13|
|Net Profit Margin||36.73%|
How did GEMC perform over the long term?See historical performance and comparison
Is GEMC undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GEMC?
Other financial metrics that can be useful for relative valuation.
|What is GEMC's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does GEMC's PE Ratio compare to its peers?
|GEMC PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
MCGS Medicare Group Q.P.S.C
MDTR Mediterranean Towers
2279 Yonghe Medical Group
GEMC United Medical Group Cy
Price-To-Earnings vs Peers: GEMC is good value based on its Price-To-Earnings Ratio (5.7x) compared to the peer average (37.9x).
Price to Earnings Ratio vs Industry
How does GEMC's PE Ratio compare vs other companies in the European Healthcare Industry?
Price-To-Earnings vs Industry: GEMC is good value based on its Price-To-Earnings Ratio (5.7x) compared to the European Healthcare industry average (17.5x)
Price to Earnings Ratio vs Fair Ratio
What is GEMC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||5.7x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GEMC's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of GEMC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GEMC (RUB403.9) is trading below our estimate of fair value (RUB1491.51)
Significantly Below Fair Value: GEMC is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is United Medical Group Cy forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GEMC's forecast earnings growth is above the savings rate (7.5%).
Earnings vs Market: Insufficient data to determine if GEMC's earnings are forecast to grow faster than the Russian market
High Growth Earnings: Insufficient data to determine if GEMC's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if GEMC's revenue is forecast to grow faster than the Russian market.
High Growth Revenue: Insufficient data to determine if GEMC's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GEMC's Return on Equity is forecast to be high in 3 years time
Discover growth companies
How has United Medical Group Cy performed over the past 5 years?
Past Performance Score4/6
Past Performance Score 4/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: GEMC has high quality earnings.
Growing Profit Margin: GEMC's current net profit margins (36.7%) are higher than last year (28.7%).
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if GEMC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare GEMC's past year earnings growth to its 5-year average.
Earnings vs Industry: GEMC earnings growth over the past year (40.8%) exceeded the Healthcare industry 19.4%.
Return on Equity
High ROE: GEMC's Return on Equity (62.8%) is considered outstanding.
Discover strong past performing companies
How is United Medical Group Cy's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: GEMC's short term assets (€96.8M) exceed its short term liabilities (€79.2M).
Long Term Liabilities: GEMC's short term assets (€96.8M) do not cover its long term liabilities (€116.2M).
Debt to Equity History and Analysis
Debt Level: GEMC's net debt to equity ratio (45%) is considered high.
Reducing Debt: Insufficient data to determine if GEMC's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: GEMC's debt is well covered by operating cash flow (81.9%).
Interest Coverage: GEMC's interest payments on its debt are well covered by EBIT (12.3x coverage).
Discover healthy companies
What is United Medical Group Cy current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GEMC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GEMC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GEMC's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GEMC's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as GEMC has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
United Medical Group Cy has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
United Medical Group Cy PLC's employee growth, exchange listings and data sources
- Name: United Medical Group Cy PLC
- Ticker: GEMC
- Exchange: MISX
- Founded: 1989
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: ₽36.351b
- Shares outstanding: 90.00m
Number of Employees
- United Medical Group Cy PLC
- The Hawk Building
- 4th Floor
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/15 00:00|
|End of Day Share Price||2022/07/08 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.